Copyright
©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5685-5694
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5685
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5685
Table 1 Clinical parameters of evaluable patients n (%)
| Alequel (n = 14) | Placebo (n = 15) | |
| Sex (M:F) | 6:8 | 6:9 |
| Age (yr), mean (range) | 35 (26-53) | 30 (19-48) |
| Duration of disease, mean | 9.1 | 7.4 |
| Location of disease | ||
| Small bowel | 8 | 6 |
| Colon | 5 | 3 |
| Both | 1 | 6 |
| Steroid treatment | 1 (7) | 3 (20) |
| Thiopurine treatment | 2 (14) | 4 (27) |
| Baseline CDAI | 303 (223-394) | 281 (228-365) |
| Baseline IBDQ | 142 | 151 |
- Citation: Israeli E, Zigmond E, Lalazar G, Klein A, Hemed N, Goldin E, Ilan Y. Oral mixture of autologous colon-extracted proteins for the Crohn’s disease: A double-blind trial. World J Gastroenterol 2015; 21(18): 5685-5694
- URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5685.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5685